chr11-112025600-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000280346.11(DLAT):c.128C>T(p.Ala43Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.363 in 1,613,720 control chromosomes in the GnomAD database, including 108,574 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000280346.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLAT | NM_001931.5 | c.128C>T | p.Ala43Val | missense_variant | 1/14 | ENST00000280346.11 | NP_001922.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLAT | ENST00000280346.11 | c.128C>T | p.Ala43Val | missense_variant | 1/14 | 1 | NM_001931.5 | ENSP00000280346 | P3 |
Frequencies
GnomAD3 genomes AF: 0.334 AC: 50799AN: 152024Hom.: 9011 Cov.: 32
GnomAD3 exomes AF: 0.380 AC: 94757AN: 249216Hom.: 18833 AF XY: 0.380 AC XY: 51395AN XY: 135082
GnomAD4 exome AF: 0.366 AC: 534478AN: 1461578Hom.: 99562 Cov.: 80 AF XY: 0.367 AC XY: 267049AN XY: 727108
GnomAD4 genome AF: 0.334 AC: 50824AN: 152142Hom.: 9012 Cov.: 32 AF XY: 0.342 AC XY: 25423AN XY: 74356
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 15, 2016 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Pyruvate dehydrogenase E2 deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at